Quadrant Private Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$391K Buy
2,802
+48
+2% +$6.72K 0.06% 208
2025
Q4
$338K Buy
+2,754
New +$335K 0.06% 207
2025
Q1
Sell
-8,256
Closed -$763K 236
2024
Q4
$763K Sell
8,256
-385
-4% -$34.7K 0.19% 112
2024
Q3
$724K Sell
8,641
-101
-1% -$7.71K 0.18% 116
2024
Q2
$600K Buy
8,742
+204
+2% +$13.6K 0.14% 129
2024
Q1
$625K Sell
8,538
-249
-3% -$19.1K 0.16% 116
2023
Q4
$712K Sell
8,787
-319
-4% -$24.8K 0.2% 104
2023
Q3
$682K Sell
9,106
-522
-5% -$40.1K 0.23% 89
2023
Q2
$742K Sell
9,628
-200
-2% -$16K 0.21% 103
2023
Q1
$815K Sell
9,828
-209
-2% -$17.3K 0.25% 93
2022
Q4
$862K Buy
+10,037
New +$795K 0.29% 88
2022
Q2
$677K Sell
10,949
-493
-4% -$30.5K 0.28% 80
2022
Q1
$680K Sell
11,442
-65
-0.6% -$4.16K 0.25% 87
2021
Q4
$836K Sell
11,507
-443
-4% -$30.5K 0.31% 80
2021
Q3
$835K Sell
11,950
-200
-2% -$14.1K 0.34% 72
2021
Q2
$837K Sell
12,150
-699
-5% -$46.7K 0.34% 70
2021
Q1
$830K Sell
12,849
-70
-0.5% -$4.51K 0.36% 70
2020
Q4
$753K Sell
12,919
-601
-4% -$36.3K 0.34% 72
2020
Q3
$854K Sell
13,520
-240
-2% -$16.6K 0.43% 62
2020
Q2
$1.06M Buy
13,760
+2,627
+24% +$201K 0.61% 41
2020
Q1
$832K Buy
+11,133
New +$769K 0.7% 37

Other funds holding GILD

Quadrant Private Wealth Management's GILD Position: Q1 2026 in Review

Quadrant Private Wealth Management increased its Gilead Sciences (GILD) stake by 1.7% in Q1 2026, buying an estimated $6.72K and bringing the position to 2,802 shares worth $391K. The position accounts for 0.06% of the portfolio, ranked #208.

Quadrant Private Wealth Management first reported a position in GILD in Q1 2020 and has held it in 21 quarters since. The position peaked at $1.06M in Q2 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Quadrant Private Wealth Management held 2,802 shares of Gilead Sciences worth $391K as of Q1 2026.
  • Quadrant Private Wealth Management bought 48 Gilead Sciences shares in Q1 2026, an estimated $6.72K.
  • Gilead Sciences made up 0.06% of Quadrant Private Wealth Management's portfolio in Q1 2026, its #208 holding.
  • Quadrant Private Wealth Management first reported a position in Gilead Sciences in Q1 2020 and has held it in 21 quarters since.
  • Quadrant Private Wealth Management's Gilead Sciences position peaked at $1.06M in Q2 2020.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Quadrant Private Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.